Close

Peregrine Pharma (PPHM) Announces Presentation of Strong Data on PS-Targeting Antibodies Similar to Bavituximab in anti-PD-L1 Therapy

Go back to Peregrine Pharma (PPHM) Announces Presentation of Strong Data on PS-Targeting Antibodies Similar to Bavituximab in anti-PD-L1 Therapy